Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract

As a result of the high approval dynamics and the growing number of immuno-oncological concepts, the complexity of treatment decisions and control in the area of cancers of the esophagus, gastroesophageal junction and stomach is constantly increasing. Since the treatment indication for PD-1 inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Baretton, Gustavo B., Lordick, Florian, Gaiser, T., Hofheinz, R., Horst, D., Lorenzen, S., Moehler, M., Röcken, C., Schirmacher, P., Stahl, M., Thuss-Patience, P., Tiemann, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620316/
https://www.ncbi.nlm.nih.gov/pubmed/37874352
http://dx.doi.org/10.1007/s00432-023-05180-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620316/
https://www.ncbi.nlm.nih.gov/pubmed/37874352
http://dx.doi.org/10.1007/s00432-023-05180-5

Ejemplares similares